Allogen Biologics

Executive Summary

Allogen Biologics, a wholly-owned subsidiary of Therapeutic Solutions International, is a private biotech company based in San Diego, focused on cellular manufacturing and biologic therapies for immunology and immuno-oncology. Founded in 2017, the company leverages a leadership team with deep expertise in immunology, immuno-oncology, and regulatory affairs to advance novel treatments. As a subsidiary, its operations are integrated with the parent company, and specific pipeline details are not publicly disclosed. Allogen Biologics is likely in the preclinical or early clinical stage, concentrating on platform development and initial candidate validation. The company's future success hinges on advancing its cellular manufacturing capabilities and demonstrating proof-of-concept in targeted indications.

Upcoming Catalysts (preview)

• Q2 2026Preclinical Data Presentation at Major Immunology Conference60% success
• Q3 2026Announcement of IND Filing for Lead Candidate40% success
• Q4 2026Partnership or Licensing Agreement for Manufacturing Platform30% success